casipharmaceuticals.com (CASI) - Volume dodolan perusahaan

CASI Pharmaceuticals currently generates cash flow through the sale of certified oncology drugs in the PRC. Business growth is supported by partnerships with global biolabs to launch new hematological agents. The company's gross sales revenue confirms the effectiveness of its strategy, with the current level standing at 0.00. However, success depends on the speed of regulatory approvals and access to China's state medical insurance.

Pendapatan lan volume dodolan: CASI Pharmaceuticals, Inc (CASI) kanggo 04.07.2022 - 14.03.2026

Rincian metrik komprehensif lan analitis CASI Pharmaceuticals Inc. (CASI)

- rega pasar lan target rega analis:

Rega bursa CASI Pharmaceuticals, Inc|CASI - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar CASI Pharmaceuticals, Inc.|CASI - Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi saben Saham CASI Pharmaceuticals|CASI - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku casipharmaceuticals.com|CASI - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

Koefisien Total Utang marang Modal CASI Pharmaceuticals|CASI - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal CASI Pharmaceuticals, Inc|CASI - Gunggung utang perusahaan|Rasio utang marang aset resik CASI Pharmaceuticals, Inc.|CASI - Utang jangka dawa perusahaan|Kewajiban jangka cendhak CASI Pharmaceuticals|Rasio jangkoan perantara casipharmaceuticals.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

CASI - Bathi resik|Proyeksi bathi mangsa ngarep CASI Pharmaceuticals|CASI - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi CASI Pharmaceuticals, Inc|CASI - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CASI Pharmaceuticals, Inc.|CASI - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) CASI Pharmaceuticals|CASI - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan casipharmaceuticals.com|CASI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep CASI Pharmaceuticals

- statistik dodolan lan pendapatan perusahaan:

CASI - Dodolan perusahaan|Prakiraan volume dodolan CASI Pharmaceuticals, Inc|CASI - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake CASI Pharmaceuticals, Inc.

Analisis umum perusahaan:casipharmaceuticals.com - CASI

Produk asil prodhuksi casipharmaceuticals.com

The indicator's dynamics are based on the continuous monitoring of daily cash inflows, which eliminates time gaps in financial reporting. This metric captures the actual volume of product sales, reflecting the pace of business expansion or customer churn. For CASI Pharmaceuticals (CASI), this flow confirms market demand for innovative therapies for oncohematological diseases. By analyzing the company's commercial revenue, an investor assesses the balance between aggressive sales growth and brand resilience.

Analisis perusahaan pesaing